Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial von Naumann, R Wendel, Hollebecque, Antoine, Meyer, Tim, Devlin, Michael-John, Oaknin, Ana, Kerger, Joseph, López-Picazo, Jose M, Machiels, Jean-Pascal, Delord, Jean-Pierre, Evans, Thomas R J, Boni, Valentina, Calvo, Emiliano, Topalian, Suzanne L, Chen, Tian, Soumaoro, Ibrahima, Li, Bin, Gu, Junchen, Zwirtes, Ricardo, Moore, Kathleen N

Volltext

The SHAPE trial: is good is good enough? von Naumann, R Wendel

Volltext

Toolbox for atomic layer deposition process development on high surface area powders von Knemeyer, K., Baumgarten, R., Ingale, P., Naumann d’Alnoncourt, R., Driess, M., Rosowski, F.

Volltext

Minimally Invasive Radical Hysterectomy Has Many Benefits Compared with Open Radical Hysterectomy: Will the LACC Trial Cause the Premature Demise of This Procedure? von Naumann, R. Wendel

Volltext

Re-evaluating “Success” as It Pertains to Surgical Trials von Naumann, R. Wendel

Volltext

Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology von Conrad, Lesley B, Ramirez, Pedro T, Burke, William, Naumann, R Wendel, Ring, Kari L, Munsell, Mark F, Frumovitz, Michael

Volltext

The role of lymphadenectomy in endometrial cancer: Was the ASTEC trial doomed by design and are we destined to repeat that mistake? von Naumann, R. Wendel

Volltext

The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage von Naumann, R. Wendel, Hughes, Brittany N., Brown, Jubilee, Drury, Lane K., Herzog, Thomas J.

Volltext

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study) von Fritsch, K, Kasenda, B, Schorb, E, Hau, P, Bloehdorn, J, Möhle, R, Löw, S, Binder, M, Atta, J, Keller, U, Wolf, H-H, Krause, S W, Heß, G, Naumann, R, Sasse, S, Hirt, C, Lamprecht, M, Martens, U, Morgner, A, Panse, J, Frickhofen, N, Röth, A, Hader, C, Deckert, M, Fricker, H, Ihorst, G, Finke, J, Illerhaus, G

Volltext

Atomic layer deposition on porous powders with in situ gravimetric monitoring in a modular fixed bed reactor setup von Strempel, V. E., Naumann d’Alnoncourt, R., Driess, M., Rosowski, F.

Volltext

Phase II study of treatment of advanced ovarian cancer with folate-receptor-targeted therapeutic (vintafolide) and companion SPECT-based imaging agent (99mTc-etarfolatide) von Morris, R.T., Joyrich, R.N., Naumann, R.W., Shah, N.P., Maurer, A.H., Strauss, H.W., Uszler, J.M., Symanowski, J.T., Ellis, P.R., Harb, W.A.

Volltext

Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer von Naumann, R. Wendel, Coleman, Robert L.

Volltext

Ovarian cancer screening with the Risk of Ovarian Cancer Algorithm (ROCA): Good, bad, or just expensive? von Naumann, R. Wendel, Brown, Jubilee

Volltext

The Role of Colonoscopy and Radiological Procedures in the Management of Acute Lower Intestinal Bleeding von Strate, Lisa L, Naumann, Christopher R

Volltext

Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial von Oaknin, Ana, Moore, Kathleen, Meyer, Tim, López-Picazo González, José, Devriese, Lot A, Amin, Asim, Lao, Christopher D, Boni, Valentina, Sharfman, William H, Park, Jong Chul, Tahara, Makoto, Topalian, Suzanne L, Magallanes, Manuel, Molina Alavez, Alejandro, Khan, Tariq Aziz, Copigneaux, Catherine, Lee, Michelle, Garnett-Benson, Charlie, Wang, Xuya, Naumann, R Wendel

Volltext

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant O... von NAUMANN, R. Wendel, COLEMAN, Robert L, GERSH, Robert H, TENERIELLO, Michael G, HARB, Wael A, KONSTANTINOPOULOS, Panagiotis A, PENSON, Richard T, SYMANOWSKI, James T, LOVEJOY, Chandra D, LEAMON, Christopher P, MORGENSTERN, David E, MESSMANN, Richard A, BURGER, Robert A, SAUSVILLE, Edward A, KUTARSKA, Elzbieta, GHAMANDE, Sharad A, GABRAIL, Nashat Y, DEPASQUALE, Stephen E, NOWARA, Elzbieta, GILBERT, Lucy

Volltext

Phase III trials in ovarian cancer: The evolving landscape of front line therapy von Naumann, R. Wendel, Coleman, Robert L., Brown, Jubilee, Moore, Kathleen N.

Volltext

Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer von Fu, Siqing, Corr, Bradley R, Culm-Merdek, Kerry, Mockbee, Colleen, Youssoufian, Hagop, Stagg, Robert, Naumann, R Wendel, Wenham, Robert M, Rosengarten, Rafael D, Benjamin, Laura, Hamilton, Erika Paige, Moore, Kathleen N

Volltext

The Benefits of Laparoscopic Radical Hysterectomy for Cervical Cancer: Res Ipsa Loquitur? von Lovell, Daniel Y., Naumann, R. Wendel

Volltext

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer von MUTCH, David G, ORLANDO, Mauro, ALVAREZ SECORD, Angeles, GOSS, Tiana, TENERIELLO, Michael G, GORDON, Alan N, MCMEEKIN, Scott D, YANPING WANG, SCRIBNER, Dennis R, MARCINIACK, Martin, NAUMANN, R. Wendel

Volltext